Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Brain Neoplasms × AZD3759 × Clear all

Phase

Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Respiratory Tract Diseases 1 Neoplasms 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

Gefitinib 2 trofosfamide 1 tozuleristide 1 Thiotepa 1 Temozolomide 1 Sunitinib 1 Magnetic Resonance Spectroscopy 1 Lomustine 1 Etoposide 1 Erlotinib Hydrochloride 1 Cholecalciferol 1 Carboplatin 1 Bevacizumab 1 AZD3759 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03653546 2025-09-10

BM

Alpha Biopharma (Jiangsu) Co., Ltd.

Phase 2/3 Completed

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Respiratory Tract Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡